Recombinant KRT20 Antibody / Cytokeratin 20
This MAb recognizes an intermediate filament protein of 46kDa, identified as CK20 (KRT20) . KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
Product Specifications
CAS Number
9000-83-3
Specifications
Immunohistochemistry (FFPE) : 1-2 µg/mL
UniProt
P35900
Host
Rabbit
Reactivity
Human
Immunogen
A portion of amino acids 324 424 was used as the immunogen for the recombinant KRT20 antibody.
Clonality
Recombinant Monoclonal
Isotype
IgG κ
Clone
KRT20/4380R
Type
Recombinant
Applications
IHC-P
Purity
Protein A/G affinity
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reconstitution
Aliquot the recombinant KRT20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This recombinant KRT20 antibody is available for research use only.
Storage Conditions
Aliquot the recombinant KRT20 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05% sodium azide
Applications Notes
Optimal dilution of the recombinant KRT20 antibody should be determined by the researcher.
Location
Cytoplasm
Image Legend
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (186-2G9), CF594 conjugate, 0.1mg/mL
Histone H1 (AE-4), CF405S conjugate, 0.1mg/mL
Cdc20 (CDC20/1102), CF647 conjugate, 0.1mg/mL
